Fang, Kun
Ohihoin, Aigbe G.
Liu, Tianxiang
Choppavarapu, Lavanya
Nosirov, Bakhtiyor
Wang, Qianben
Yu, Xue-Zhong
Kamaraju, Sailaja
Leone, Gustavo
Jin, Victor X. https://orcid.org/0000-0002-8765-3471
Article History
Received: 4 March 2024
Accepted: 7 November 2024
First Online: 18 November 2024
Declarations
:
: This study uses previously collected breast cancer patients’ pathological specimens, or diagnostic specimens from various biospecimen resources that have already been granted local Institutional Review Board (IRB) protocol approvals. All patients’ samples are de-identified but included with some basic clinical features. We will not have any keys that may link specific Health Insurance Portability and Accountability Act (HIPAA)-defined protected health information (PHI) to specific individuals. Medical College of Wisconsin has granted this study without an IRB; therefore, ethics approval was waived in this case. This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.